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The development of autoimmune diabetes in 
both humans and nonobese diabetic (NOD) 
mice is highly influenced by specific alleles of 
the class II MHC genes: HLA-DQ2 and HLA-
DQ8 in humans and I-Ag7 in mice (Acha-Orbea 
and McDevitt, 1987; Cucca et al., 2001). CD4+ 
T cells are essential in initiating the autoim-
mune response and, consequently, much empha-
sis has been placed on deciphering the relevant 
self-peptides recognized by these cells driving 
the development of diabetes (Anderson and 
Bluestone, 2005).
The work of many laboratories has empha-
sized the importance of insulin as a critical tar-
get of the immune response for the development 
of autoimmune diabetes (Zhang et al., 2008). 
Extensive analysis of the T cell response directed 
against insulin has highlighted an immunodomi-
nant segment of the insulin B chain, the B:9-23 
(SHLVEALYLVCGERG) peptide (Wegmann 
et al., 1994a,1994b; Daniel et al., 1995; Abiru 
et al., 2001; Halbout et al., 2002). CD4+ T cells 
recognizing B:9-23 are detected within the infil-
trated islets of prediabetic mice and antigenic 
masking of this epitope via mutation or tolero-
genic expression in APCs diminished islet auto-
immunity, signifying the essential role recognition 
of the B:9-23 epitope in the development of dia-
betes (French et al., 1997; Jaeckel et al., 2004; 
Nakayama et al., 2005). These studies and others 
convincingly show that insulin is among the fore-
most targets in NOD diabetes, and its recogni-
tion by CD4+ T cells likely initiates a cascade of 
downstream events driving both the amplifi-
cation and diversification of the autoimmune 
response, ultimately resulting in the complete 
destruction of  cells (Nakayama et al., 2007; 
Krishnamurthy et al., 2008). As a result, much 
importance has been placed on understanding 
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In the nonobese diabetic mouse, a predominant component of the autoreactive CD4+ T cell 
repertoire is directed against the B:9-23 segment of the insulin B chain. Previous studies 
established that the majority of insulin-reactive T cells specifically recognize a weak peptide-
MHC binding register within the B:9-23 segment, that to the 12–20 register. These T cells 
are uniquely stimulated when the B:9-23 peptide, but not the insulin protein, is offered to 
antigen presenting cells (APCs). Here, we report on a T cell receptor (TCR) transgenic mouse 
(8F10) that offers important new insights into the biology of these unconventional T cells. 
Many of the 8F10 CD4+ T cells escaped negative selection and were highly pathogenic. The 
T cells were directly recruited into islets of Langerhans, where they established contact with 
resident intra-islet APCs. Immunogenic insulin had to be presented in order for the T cells to 
localize and cause disease. These T cells bypassed an initial priming stage in the pancreatic 
lymph node thought to precede islet T cell entry. 8F10 T cells induced the production of 
antiinsulin antibodies and islets contained immunoglobulin (IgG) deposited on  cells and 
along the vessel walls.
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RESULTS
Generation of the 8F10 TCR transgenic mouse strain
The 8F10 TCR transgenic mouse was generated using the 
rearranged TCR  chain (V13.3, TRAV5D-4/TRAJ53) 
and  chain (V8.2, TRBV13-2/TRBD2/TRBJ2-7) cloned 
from the 8F10 B:9-23 reactive type B T cell. In prior studies, 
the 8F10 T cell exhibited strong reactivity for APC pulsed 
with the B:9-23 peptide, while remaining completely unre-
active to APC pulsed with the insulin protein. These T cells 
specifically recognized the type B register 12–20, but com-
pletely lacked a response to the type A register 13–21 (Mohan 
et al., 2010, 2011).
A single founder was obtained with genotypic and phe-
notypic characteristics indicative of a co-integration of both 
the TCR  and  chains into a single genetic locus. The total 
numbers of cells found in the thymus or spleen of 8F10 mice 
were similar to those found in NOD mice. Flow cytometric 
analysis of thymus and spleens showed normal T cell devel-
opment in 8F10 mice (Fig. 1 A). The detection of T cells in 
the periphery of 8F10 mice implicated their escape from neg-
ative selection in the thymus. The ratio of CD4+ versus CD8+ 
T cells was increased in both the thymus and to a lesser extent 
in the spleen of 8F10 mice compared with NOD. As expected, 
the development of CD8+ T cells was impaired in 8F10 mice, 
seen by their reduced number in thymus and spleen, asserting 
the notion that the TCR of 8F10 primarily interacts with the 
MHC class II allele I-Ag7.
The vast majority (>95%) of CD4+ cells in 8F10 mice 
stained positive with the TCR V8.1/8.2 antibody compared 
with 20–25% of T cells in littermate controls (Fig. 1 B). 
Expression of other TCR V alleles on 8F10 T cells was not 
observed, thereby confirming allelic exclusion of the endog-
enous TCR  locus.
Currently, there is no available antibody that recognizes 
the TCR V13.3 allele, so we could not assess the level of 
surface expression for the transgenic TCR V chain. How-
ever, despite strong allelic exclusion of the endogenous TCR 
V locus, many of the peripheral T cells in 8F10 mice exhib-
ited successful rearrangements of endogenous TCR  chains. 
Staining with an antibody that recognizes the TCR V2 allele 
showed that a subset of 8F10 CD4+ T cells expressed this 
particular TCR  chain (Fig. 1 B). Other minor populations 
of 8F10 T cells expressed TCR V3.2, TCR V3.2, or TCR 
V8.3, pointing to a significant fraction of transgenic T cells 
expressing additional endogenous TCR  chains. This feature 
is not unique to the 8F10 strain, as other TCR transgenics 
expressed functional rearrangements of endogenous TCR  
gene products (Zal et al., 1994; Fousteri et al., 2012; Mingueneau 
et al., 2012). The majority of the splenic CD4+ T cells in 8F10 
mice exhibited a naive phenotype, proven by the predomi-
nance of CD62Lhi CD44low T cells (Fig. 1 C).
To restrict the TCR repertoire, 8F10 mice were crossed 
onto the recombinase activating gene 1 (rag1)–deficient back-
ground. Crossing 8F10 mice onto the rag1-deficient back-
ground prevented the rearrangement of endogenous TCR 
 chains, thus ensuring that only the transgenic TCR/ 
the precise details involved in the recognition of the B:9-23 
peptide by the immune system, particularly its binding inter-
actions with I-Ag7 and the nature of the self-reactive T cells that 
recognize this peptide MHC complex (Abiru et al., 2000; Yu 
et al., 2000; Levisetti et al., 2007; Crawford et al., 2011; Mohan 
et al., 2011).
Recently, we described a unique set of diabetogenic insu-
lin-reactive CD4+ T cells that constitute the major component 
of the T cell repertoire recognizing the B:9-23 peptide (Mohan 
et al., 2010, 2011; Mohan and Unanue, 2012). Unlike conven-
tional T cells, these T cells specifically recognized exogenous 
insulin peptides offered to the APCs, but were incapable of rec-
ognizing the same peptide generated from processing of the in-
sulin protein by the APC. The conventional T cells, referred to as 
type A, represented a very small minority (<1%) of the T cells 
recognizing the B:9-23 peptide. The unconventional T cells, 
referred to as type B, were abundant (>99% of the T cells rec-
ognizing this peptide) in the periphery of NOD mice, indicating 
that they might be impervious to negative selection in the thy-
mus during development. A single amino acid shift of the B:9-23 
peptide segment bound within the groove of I-Ag7 decisively 
explained the discordant reactivities between type A and B 
T cells (Mohan et al., 2011). Type A T cells recognized the 
13–21 segment (SHLEALYVLVCGERG [sequence in bold, 
the critical P9 residue in bold and italic]) of the B:9-23 peptide 
bound to I-Ag7. In contrast, type B T cells recognized the 12–20 
segment of the peptide (SHLVEALYLVCGERG [sequence 
in bold, the critical P9 residue in bold and italic]) bound to 
I-Ag7. The 13–21 register (type A) interacts more favorably with 
I-Ag7, whereas the 12–20 register (type B) is largely unstable 
and rapidly dissociates from I-Ag7. Importantly, free peptides 
from insulin catabolism were identified in  cell secretory 
granules and in the islet APCs, explaining the presentation of 
the 12–20 register to the type B T cells (Mohan et al., 2010). It 
is therefore highly plausible that the binding features and lack 
of presentation of the 12–20 register after processing of insulin 
protein explain why type B T cells are capable of escaping thy-
mic selection.
Understanding the biology of these type B T cells that 
recognize the weak binding register of the B:9-23 peptide, 
only presented by APC from preformed peptides, requires a 
TCR transgenic mouse. Here, we report on the generation 
of a type B TCR transgenic (8F10) mouse specific for the 
12–20 segment of the insulin B chain and show that these T cells 
escape negative selection in the thymus, are spontaneously 
recruited to the islets by intra-islet APCs charged with insu-
lin peptide–MHC complexes, induce local inflammation, 
and are highly pathogenic in the absence of other T cell spec-
ificities. The initial activation of these diabetogenic T cells does 
not appear to occur in the pancreatic LNs (PLNs); instead, 
they are directly recruited into islets from the vascular net-
work through interactions with resident intra-islet APCs. Their 
biological properties appear unique and quite different from 
other insulin T cells described, specifically those with type A 
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Response of 8F10 TCR transgenic T cells  
to the B:9-23 peptide
CD4+ T cells from the spleen of 8F10 mice responded robustly 
to the B:9-23 peptide but did not respond to APC pulsed with 
the insulin protein, confirming the type B reactivity previ-
ously reported using the parental T cell line (Fig. 2 A). As the 
B:9-23 peptide binds in multiple overlapping registers to the 
I-Ag7 molecule, we next examined their register reactivity 
using nested register peptides, each of which contained a sin-
gle binding register present within the B:9-23 peptide (Mohan 
et al., 2011). As expected, these T cells responded robustly 
to the weaker MHC binding B:12-20 register, poorly to the 
stronger MHC binding B:13-21 register and had no response 
to the very weak MHC binding register B:14-22 reported 
by others (Crawford et al., 2011) when presented by I-Ag7 
(Fig. 2 B). T cells from 8F10 rag1/ mice behaved in a simi-
lar manner, responding robustly to the B:9-23 peptide and 
the 12–20 register but poorly to insulin and the 13–21 register 
(Fig. 2, C and D). T cells from 8F10 rag1/ mice also recog-
nized a nested 12–21 peptide, containing the minimal sequence 
of both registers in tandem recognized by both type A and B 
chains were expressed. Although the majority of thymo-
cytes in 8F10 rag1/ mice were found in the immature 
CD4/CD8 double positive population, a small proportion 
of these cells matured into CD4+ single-positive T cells 
(Fig. 1 D). Despite the low level of thymic selection in 
8F10 rag1/ mice, T cells were present in the periphery 
and were exclusively CD4+, representing roughly 5–10% 
of the total splenocytes (Fig. 1 D and Discussion). 8F10 
rag1/ mice contained a similar number of thymocytes 
compared with 8F10 mice, but the number of splenocytes 
was reduced (Fig. 1 E).
A subset of CD4+ single-positive 8F10 thymocytes ex-
pressed the regulatory T cell (T reg) marker Foxp3. In the 
spleen, a sizable proportion (10–15%) of CD4+ T cells 
expressed Foxp3 (Fig. 1 F). Foxp3 expressing T cells were 
extremely rare, if not entirely absent in both the thymus 
and periphery of 8F10 rag1/ mice (Fig. 1 F). Thus, the de-
velopment of T reg cells in 8F10 mice was dependent on 
the expression of rearranged endogenous TCR  chains, 
which was prevented when the mice were bred to a rag1-
deficient background.
Figure 1. Analysis of 8F10 mice. (A, left) CD4 and CD8 flow cytometric profiles of NOD and 8F10 thymocytes; (right) percentages of cells found 
among individual 8F10 mice. (B) Cell surface staining of 8F10 and NOD CD4+ splenocytes with anti-TCR V8.1/8.2 (left) or anti-TCR V2 (right). (C) Cell 
surface staining of 8F10 CD4+ splenocytes with anti-CD44 and -CD62L. (D) Thymic (top left) and splenic (bottom left) profiles, and percentages of T cells 
among individual 8F10 rag1/ mice (right). (E) Absolute number of thymocytes and splenocytes from 8F10 and 8F10 rag1/ mice. (F, left) Foxp3 stain-
ing of CD4+ single-positive thymocytes and CD4+ splenocytes of 8F10 and 8F10 rag1/ mice; (right) percentages of Foxp3+ T cells from individual 8F10 
and 8F10 rag1/ mice. (A–F) Representative flow cytometry plots and cumulative data from two or more independent experiments (error bars, SEM). 
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blood vessel walls (Fig. 3 D). In experiments in which non-
specific IgG was injected into mice, we did not observed local-
ization in islets. The sera of 8–12-wk-old 8F10 mice contained 
antibodies to native insulin, which were completely blocked 
by the addition of soluble insulin in the assay (Fig. 3 E). The 
antisera did not react with denatured insulin, B:9-23 peptide, 
or with Nit-1 insulinoma cell membranes (Levisetti et al., 2003). 
Sera from NOD mice did not show detectable levels of anti-
insulin antibodies in our assay at this time. These observations 
suggest that antiinsulin antibodies are made inside islets and 
form immune complexes with insulin. The number of B cells 
inside the islets during the early 8–12-wk period at the time 
that antibodies were found was about one per islet (in 155 islets 
examined). B cells were found in only 10% of the islets of non-
diabetic NOD mice at the 8–12-wk period; this limited num-
ber has made it difficult at this point to establish their reactivity 
(Carrero et al., 2013). Further studies aimed at characterizing 
their specificity are currently in progress.
To gain a better understanding of the importance of an-
tigen specificity in the recruitment of T cells into the islets, 
we transplanted bone marrow cells of 8F10 rag1/ mice into 
lethally irradiated B16:A-dKO mice (B16A). These mice ex-
press a single insulin gene with a tyrosine-to-alanine muta-
tion at the 16th residue of the B:9-23 peptide and do not 
develop diabetes (Nakayama et al., 2005). This mutation com-
pletely abrogates the antigenicity of the B:9-23 peptide for 
both type A and B CD4+ T cells (Abiru et al., 2000, Mohan 
et al., 2010). 8F10 localized to islets of NOD mice, whereas 
localization was minimal in B16A mice. Unmanipulated B16A 
mice showed minimal localization into islets when compared 
with regular NOD mice (Fig. 3 F). Furthermore, diabetes de-
veloped in irradiated NOD mice transplanted with bone mar-
row of 8F10 rag1/ but not in B16A mice that received 
the same cells (Fig. 3 F). To note, but not shown in Fig. 3, 
is that a different CD4+ T cell, the BDC 2.5, induced diabetes 
when adoptively transferred into irradiated B16A mice: 6/6 
were diabetic within 8 d after the transfer of 4 × 106 acti-
vated T cells.
insulin-reactive T cells. The reactivity to the nested 12–21 pep-
tide was similar to the response observed for the B:9-23 pep-
tide, both of which were weaker than the response observed 
for the nested 12–20 peptide (Fig. 2 D). When APCs are of-
fered the B:9-23 and the nested 12–21 peptide they bind to 
I-Ag7 in multiple independent registers, thus partially dimin-
ishing the response compared with the nested 12–20 peptide 
that specifically binds in the sole register, recognized by the 
8F10 TCR. As expected, in six different trials islet APCs 
presented to 8F10 as shown previously for all insulin-reactive 
T cells (Mohan et al., 2010).
T cell entrance into islets
Immunofluorescence microscopy of isolated islets showed 
the presence of 8F10 T cells within the islets at 3 wk of age, 
the first point examined. At 5–10 wk of age, 60% of the 
islets contained anywhere from a single T cell to >50 per islet 
(Fig. 3 A). Older mice exhibited even further infiltration, 
with roughly 90% of islets containing T cells and an overall 
greater mean T cell burden per islet (Fig. 3 B). A phenotypic 
analysis of the intra-islet T cells is described in the next sec-
tion. Induction of VCAM-1 in intra-islet vessels was also ob-
served in the infiltrated islets of 8F10 mice (Fig. 3, A and B). 
VCAM-1 is an adhesion molecule not expressed in resting 
islets, but rapidly up-regulated upon entrance of diabetogenic 
T cells (Calderon et al., 2011a). Many of the T cells found 
inside the islets were in direct contact with the resident intra-
islet APCs (Fig. 3 C). We previously reported that the resident 
intra-islet APCs were heavily charged with B:9-23 peptide–
MHC complexes and stimulated B:9-23 reactive T cell hybrid-
omas ex vivo (Calderon et al., 2008; Mohan et al., 2010). These 
findings are in line with the notion that the resident intra-islet 
APCs provide the local stimulatory signal within the islets to 
infiltrating T cells.
IgG deposition was detected in many islets in 8F10 mice, 
suggesting the presence of islet autoantibodies (Fig. 3 D). IgG 
was found on the surface of the majority of islet cells in a speck-
led pattern and, intriguingly, in discrete deposits along the islet 
Figure 2. Reactivity of 8F10 CD4+ T cells. (A) Primary 
proliferation of isolated 8F10 CD4+ T cells in response to  
B:9-23 peptide and insulin protein presented by CD11c+ 
DCs. (B) Primary proliferation of isolated 8F10 CD4+ T cells in 
response to nested register peptides (core peptides) contain-
ing a single register of the B:9-23 peptide presented by 
CD11c+ DCs. (C) Primary proliferation of splenocytes isolated 
from 8F10 rag1/ mice incubated with insulin or B:9-23 
peptide. (D) Enzyme-linked immunospot (ELISPOT) assay of 
IL-2 secretion by splenocytes isolated from 8F10 rag1/ 
mice pulsed with the B:9-23 peptide, insulin protein, or 
nested register peptides (core peptides). (A–D) Data repre-
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histological examination. The heterogeneous nature in islet 
pathology may well be related to the variations in the number 
of resident intra-islet APC, which can vary from a single APC 
to >10 APCs per islet (Calderon et al, 2008, 2012).
8F10 mice did not develop diabetes even when followed 
for >8 mo, despite the inflammation observed in the majority 
of islets. The finding of inflammation in which the periinsulitic 
lesion predominates rather than a more destructive insulitis was 
indicative of a level of suppression controlling  cell destruc-
tion. In support of this notion, 23% (±5%) of the T cells isolated 
from islets were Foxp3+ (Fig. 4 C). The majority of T cells in 
the islets, 93.2% (±3%), expressed low levels of CD62L, indicat-
ing an activation status. In contrast, the LN T cells expressed 
high levels of CD62L, indicating a clear difference between 
those in LNs (naive status) and those inside islets (Fig. 4 C).
Strikingly, when the 8F10 mice were crossed onto a rag1-
deficient background to exclude both endogenous TCR  
chain rearrangements and the development of Foxp3 T reg cells, 
all 8F10 rag1/ mice rapidly developed diabetes, with the ma-
jority of mice succumbing to disease at 4–7 wk of age (Fig. 4 
D and 4E). The pathological finding was restricted to the islets, 
Therefore, the localization of 8F10 T cells in islets is anti-
gen specific and requires the recognition of insulin peptides. 
The mechanisms of 8F10 T cell entry are currently under in-
vestigation, but preliminary results indicate that the entry does 
not appear to involve chemokines, as treatment with pertussis 
toxin did not block their entrance. In conclusion, type B re-
active 8F10 T cells specifically infiltrated islets, initiated local 
reactivity, and induced conformational antiinsulin autoanti-
bodies analogous to those often found in the serum of type 1 
diabetics and human patients at high risk.
Pathogenicity of 8F10 T cells
The development of histopathological lesions in the islets of 
8F10 mice is shown in Fig. 4 A. Lymphocytic infiltration was 
evident at 3 wk of age and increased as the mice aged. By 12 wk 
of age, extensive infiltration was observed in the majority of 
islets (Fig. 4 A). Islet infiltration was heterogeneous, some islets 
exhibited a complete elimination of  cells, and some exhib-
ited mild intra-insulitis, while many others exhibited strong 
periinsulitic lesions with unaffected  cells (Fig. 4 B). A subset 
(20% of islets) showed no signs of lymphocytic infiltration by 
Figure 3. Recruitment of 8F10 T cells to 
islets and islet reactivity. Islet cytology 
evaluation of 8F10 female mice at 8–10 (A) or 
14–19 (B) wk of age. (A and B, left) Number of 
T cells (CD4+ or V8.1/8.2+) per individual 
islet; bars indicate the median number of  
T cells per islet. (A and B, right) Percentage of 
islets positive for CD4+ T cells, V8.1/8.2+  
T cells, VCAM-1+ expression on vessels and 
mouse IgG+ deposition from pooled islets  
(n = 5 mice per group) and 100 islets screened 
for each marker. (C) Representative immuno-
fluorescence image of an islet from A show-
ing T cells by V8.1/8.2+ staining. Insets show 
T cell–APC contacts. (D) Representative islet 
from A showing mouse IgG deposition on the 
 cells (left). Inset shows IgG+ deposition on 
 cell membrane. (right) IgG+ deposition 
found along intra-islet vessels from A.  
(E) Radiolabeled I-125 insulin response of 
antiinsulin antibody or 8F10 mouse sera  
(8–12 wk) in the presence or absence of com-
peting insulin (INS). (F) Unmanipulated con-
trols (NOD and B16A) and bone marrow 
chimeric mice (8F10/B16A and 8F10/NOD) 
indicating the number of CD4+ T cells and the 
percentages of islets containing T cells; bars 
indicate the median number of T cells per 
islet. Indicated is diabetes incidence of irradi-
ated B16A and NOD recipients reconstituted 
with 8F10 rag1/ bone marrow. (A–F) All 
data representative of two or more indepen-
dent experiments (error bars, SEM). Bars,  
50 µm. Statistical analysis Mann-Whitney  
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8F10 T cells do not require PLNs
A longstanding tenet in autoimmunity is that LNs draining 
the target tissue are important in the priming of autoreactive 
lymphocytes. Strong evidence indicates that the initiation of dia-
betogenesis commences with the priming of islet reactive T cells 
in the PLNs before their recruitment to the islets (Höglund 
et al., 1999; Calderon and Unanue, 2012). Indeed, NOD mice 
lacking the PLN did not develop diabetes and for the most 
part were devoid of overt islet infiltration (Gagnerault et al., 
2002; Levisetti et al., 2004). Furthermore, findings of two dia-
betogenic TCR transgenic models, namely BDC 2.5 and 8.3-
NOD, representing islet CD4+ and CD8+ T cells, respectively, 
showed their proliferation in the PLNs from an early age. The 
results suggest that priming of diabetogenic T cells in the PLNs 
precedes the migration of these T cells into the islets (Höglund 
et al., 1999; Zhang et al., 2002). How exactly the PLN func-
tions in T cell priming and its requirement in localization of 
T cells to the islets are not entirely known.
Previously, we reported that insulin-reactive T cells recog-
nized endogenous presentation of B:9-23 by resident intra-islet 
and no pathology was found in the ovaries, adrenals, thyroid, 
liver, or kidneys. Thus, there was a dramatic shift in the patho-
genicity of these T cells in 8F10 rag1/ mice. Splenocytes 
from diabetic 8F10 rag1/ mice were highly pathogenic when 
transferred into adult NOD rag1/ recipients at low num-
bers of T cells (104 splenocytes contained 500 to 1,000 CD4+ 
T cells; Fig. 4 F). These findings with 8F10 are compatible 
with earlier studies involving the BDC 2.5 TCR transgenic 
mouse extensively studied by the Mathis-Benoist labora-
tory, which also exhibited a level of regulation and greatly 
enhanced pathogenicity when bred to a rag1-deficient back-
ground (Gonzalez et al., 2001; Chen et al., 2005).
In conclusion, 8F10 T cells can initiate and potently cause 
diabetes in the absence of any other T cell specificities and 
T reg cells. It is important to note that the diabetes incidence 
in these mice, whose T cells specifically recognize the weaker 
of the two registers present in the B:9-23 peptide, is consider-
ably more rapid and penetrant when compared with other re-
ported B:9-23 TCR transgenic strains (Du et al., 2006; Jasinski 
et al., 2006).
Figure 4. 8F10 T cells are specifically recruited 
to the islets and are highly pathogenic. (A) Insuli-
tis scoring of pancreatic sections from 8F10 mice 
stained with hematoxylin and eosin (n = 4–7 mice 
per age group). (B) Hematoxylin and eosin–stained 
pancreatic section from a representative islet of a  
6-wk-old 8F10 mouse showing the periinsulitic  
lesion. (C) Flow cytometry analysis of islet-infiltrating 
8F10 CD4+ T cells and T cells from other anatomical 
locations (PLN, ILN [inguinal LN], and spleen) in  
10-wk-old 8F10 mice. Dispersed islets were pooled 
from 4 mice. (D) Pancreatic section from a diabetic  
5-wk-old 8F10 rag1/ mouse showing an islet with 
destructive insulitis. (E) Spontaneous diabetes inci-
dence in 8F10 (n = 60) and 8F10 rag1/ mice  
(n = 22). (F) Adoptive transfer of splenocytes from 
8F10 rag1/ mice into NOD rag1/ recipient mice 
(106, n = 10; 105, n = 8; 104, n = 4). (A–F) Cumulative 
data pooled from at least two independent experi-
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and results in mice devoid of LNs which remain absent for 
their lifespan (Rennert et al., 1996, 1998; Mandik-Nayak 
et al., 2002; Levisetti et al., 2004). 8F10 mice exposed to solu-
ble LTR-Ig in utero (8F10 nodeless) had absent axillary, ingui-
nal LN (ILN), and popliteal LNs, and of particular relevance 
to this study, they also lacked the PLN. Importantly, 8F10 node-
less mice did not exhibit any discernible differences in the 
splenic T cell repertoire compared with T cells that developed 
in 8F10 mice.
Immunofluorescence of isolated islets from 8F10 nodeless 
mice indicated that a large proportion of islets were infiltrated 
with T cells by 5 wk of age (Fig. 6 A). The level of islet T cell 
infiltration in 8F10 nodeless mice was on par with the amount 
of infiltration observed in normal 8F10 mice (Fig. 6 B). His-
tological analysis showed mononuclear infiltrates in the islets 
of 8F10 nodeless mice (Fig. 6 C). Furthermore, 8F10 rag1/ 
nodeless mice developed diabetes with similar kinetics to 
8F10 rag1/ mice (Fig. 6, D and E). Hence, the PLN is dis-
pensable for the recruitment of 8F10 T cells into the islets, 
and the development of diabetes in 8F10 rag1/ mice does 
not depend on an initial priming stage in the PLN.
DISCUSSION
In this study, we report on the unique biological features of an 
important set of insulin-reactive CD4+ T cells, those that rec-
ognize the weak 12–20 register of the insulin B:9-23 segment. 
APCs but not by APCs in the draining PLN (Mohan et al., 
2010). These results were unexpected but not entirely con-
clusive, as ex vivo T cell assays are far less sensitive than those 
performed in vivo. In light of these issues and the finding of 
8F10 T cells in islets from an early age, we tested the role of 
the PLN in priming of insulin-reactive T cells in vivo. Adop-
tively transferred, CFSE-labeled 8F10 CD4+ T cells did not 
proliferate in the PLN of recipient NOD mice that ranged in 
age from 4 to 13 wk old (Fig. 5, A and B). The lack of prolif-
eration observed with 8F10 T cells in the PLN or other nearby 
LNs, did not appear to result from active suppression as 8F10 
T cells also failed to proliferate in the absence of CD25+ cells 
(Fig. 5 C). 8F10 T cells proliferated vigorously in vitro in the 
presence of APC and antigen (Fig. 5 D). Finally, despite the 
lack of reactivity in the PLN, 8F10 T cells were recruited to 
the islets and proliferated locally, most likely triggered by the 
resident intra-islet APC (Fig. 5 E). In agreement with others, 
we found that the BDC2.5 TCR transgenic T cells prolifer-
ated in the PLN (Fig. 5 F). The results summarized in Fig. 5 G, 
indicate that unlike other diabetogenic T cells, 8F10 T cells 
are only stimulated directly within the islets and not in the 
draining PLN.
To study the role of the PLN we generated 8F10 mice 
that lacked most LNs by treating pregnant mice with a solu-
ble lymphotoxin -receptor (LtR-Ig) decoy protein. This 
treatment inhibits the development of most LNs in progeny 
Figure 5. 8F10 T cells are not effectively 
primed in the PLN. CFSE dilution of 8F10 
CD4+ T cells in the PLN of recipient NOD mice 
of the indicated ages at days 3 (A) and 5 (B) 
after transfer and analyzed by flow cytometry. 
(C) CFSE dilution of purified transferred  
CD4+ CD25 8F10 T cells in the PLNs of NOD 
mice. (D) In vitro CFSE dilution of purified 
8F10 CD4+ T cells in the presence of irradi-
ated splenocytes pulsed with B:9-23 peptide. 
(E) CFSE dilution of 8F10 CD4+ T cells trans-
ferred and isolated from the islets of  
8-wk-old NOD mice. (F) CFSE dilution of BDC 
2.5 CD4+ T cells in the PLN of 8-wk-old NOD 
mice.(G) Pooled results from multiple experi-
ments depicting percentage of divided 8F10 
and BDC 2.5 CD4+ T cells in the ILN, PLN, and 
islets of NOD recipients. Representative data 
of at least two independent experiments (A–F) 
or cumulative data of 2–6 independent ex-
periments (G; error bars, SEM; ns, not signifi-
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of the mature hormone from the prohormone is subjected to a 
specific proteolytic program; and lastly, the biochemical fea-
tures of the 12–20 register, namely, its poor binding to I-Ag7 re-
duces the chances for efficient presentation. In toto, it is likely 
that the combination of these features result in the inability to 
purge 8F10 T cells, despite their inherent pathogenicity.
Concerning the sites of presentation in peripheral sites, 
either splenic and/or blood-borne APCs could potentially 
take up and present insulin molecules circulating through the 
bloodstream. Systemic presentation has not been observed, 
likely because of the low concentration of insulin in blood 
coupled with the weak interaction of B:9-23 with I-Ag7. The 
third location, the PLN which drains the pancreas, represents an 
important site, having been shown to prime diabetogenic T cells 
and as necessary for the development of diabetes (Höglund 
et al., 1999; Gagnerault et al., 2002; Turley et al., 2003; 
Levisetti et al., 2004;). Surprisingly, insulin was presented 
either very weakly or not at all in the PLNs. The biochemical 
features of this peptide, namely the short lifespan of the regis-
ter bound to I-Ag7, likely explains the lack of detectable pre-
sentation of B:9-23 in the PLN.
8F10 T cells were recruited to the islets from an early age, 
indicating that either denatured insulin or free B chain peptides 
The 8F10 T cells: (a) evaded negative selection and peripher-
alized; (b) entered the islets of Langerhans, where they inter-
acted with resident intra-islet APCs and were pathogenic; 
(c) did not require priming in the PLN to cause diabetes; and 
(d) served as helper cells inducing antiinsulin antibodies to 
native insulin, despite their reactivity to only a preformed 
peptide segment of the insulin molecule.
These mice provide new insights into the anatomical loca-
tion where autoreactive T cells recognize insulin. There are four 
potential anatomical sites for presentation of insulin: (a) centrally 
by the thymic APC system; (b) by APC of various secondary 
lymphoid organs; (c) specifically by APC in the PLN; and (d) by 
resident APCs found in the islets of Langerhans. First, the thy-
mus epithelium is known to express insulin under the control of 
AIRE to purge the T cell repertoire of insulin-reactive cells 
(Anderson et al., 2002). Thymic insulin expression likely ac-
counts for the strong selection against type A B:9-23 reactive 
T cells. Under normal conditions, however, T cells that recog-
nize the unstable 12–20 register akin to 8F10 T cells, are not in-
teracting or interacting poorly with insulin-expressing APC in 
the thymus for several complementary reasons: expression of 
insulin by epithelial cells is too low; processing of insulin in the 
thymus is different from that in  cells in which the generation 
Figure 6. Islet-infiltrating 8F10 T cells do not 
require priming in the PLN. (A) Immunofluores-
cence of a representative islet from 5-wk-old 8F10 
nodeless mice. Inserts show T cell–APC contacts. 
(B) Quantitative analysis showing percentage of  
infiltrating CD4+ T cells in islets of 5-wk-old 8F10  
and 8F10 nodeless mice. (C) Hematoxylin and eosin–
stained pancreatic section from a 12-wk-old 8F10 
nodeless mouse. (D) Hematoxylin and eosin–stained 
pancreatic section from a 5-wk-old 8F10 rag1/ 
nodeless diabetic mouse. (E) Spontaneous diabetes 
incidence of 8F10 (n = 10), 8F10 nodeless (8F10 NL,  
n = 9), 8F10 rag1/ (8F10 rag1/, n = 4), and 8F10 
rag1/ nodeless (8F10 Rag rag1/ NL, n = 6) mice. 
Representative (A, C, and D) or cumulative (B and E) 
data pooled from two to three independent experi-











Published October 14, 2013
JEM Vol. 210, No. 11 
Article
2411
One issue to discuss concerns the lymphopenia observed 
in the peripheral compartment of 8F10 rag1/ mice. This 
result was somewhat unexpected because prior studies have 
shown that B:9-23-reactive type B T cells did not appear to 
be under selective pressure in thymus (Mohan et al., 2010, 
2011). Generally, it has been assumed that lymphopenia ob-
served in the periphery of TCR transgenics on rag1-deficient 
backgrounds was indicative of negative selection against the 
TCR of investigation. Although this explanation may be valid 
in certain instances for TCR transgenic models, it should be 
noted that this is not always the case. Contrary to this notion, 
a recent study convincingly shows that a highly restricted mono-
clonal TCR expression profile in the thymus, particularly on 
the NOD background, can result in insufficient positive selec-
tion, thus also augmenting the ability of TCR transgenic T cells 
to mature and peripheralize (Mingueneau et al., 2012). Spe-
cifically, early expression of TCR transgenes leads to overseed-
ing of the double-positive thymocyte compartment in NOD 
mice, generating heightened competition for positive selec-
tion niches, and thereby reducing the likelihood that many of 
these developing T cells will be effectively positively selected 
by a limited pool of selecting ligands. In agreement with this 
model, our study found ample rearrangement of endogenous 
TCR chains in 8F10 mice and an abundant pool of double-
positive thymocytes in 8F10 rag1/ mice, suggesting similar 
mechanisms may be involved. Whether insufficient positive 
selection can explain the low number of CD4+ T cells observed 
in 8F10 rag1/ mice will require further investigation, but it 
represents a highly plausible explanation, especially when taken 
in consideration with our previous studies showing a lack of 
negative selection against type B B:9-23-reactive T cells in the 
polyclonal repertoire of NOD mice (Mohan et al., 2010, 2011).
A final issue to note is that 8F10 rag1/ mice exhibited a 
much more rapid and penetrant diabetic process compared 
with two other B:9-23-reactive TCR transgenic strains on 
rag1-deficient backgrounds. One insulin-reactive strain (2H6), 
presumably with type A reactivity, did not exhibit islet pathol-
ogy and was shown to have suppressive qualities (Du et al., 2006). 
The second strain (BDC 12–4.1), created by the Eisenbarth 
laboratory (Jasinski et al., 2006), was included in our earlier 
studies of type A and B insulin-reactive T cells. CD4+ T cells 
from these mice were conclusively shown to exhibit type A 
reactivity, solely reacting with the stronger 13–21 binding reg-
ister of the B:9-23 peptide (Mohan et al., 2011). Paradoxi-
cally, significantly fewer of the BDC 12–4.1 rag1/ mice 
developed diabetes, and they contained a sizable population 
of T reg cells compared with 8F10 rag1/ mice (Jasinski 
et al., 2006; Fousteri et al., 2012). In toto, it suggests that strong 
selective pressure is being exerted on type A 13–21 reactive 
T cells, whereas considerably less selective pressure is exerted 
on T cells recognizing the type B 12–20 register. We specu-
late that in the naturally arising polyclonal T cell repertoire of 
NOD mice, selective pressure will eliminate the majority of 
type A B:9-23 reactive T cells, but the limited number that 
do escape selection have a much greater likelihood of devel-
oping regulatory or anergic phenotypes in the periphery. The 
were naturally and constitutively presented there. Indeed, we 
previously reported on the finding of insulin peptides within 
most of the resident intra-islet APCs, a finding compatible 
with the present identification of 8F10 T cells establishing 
intimate contacts with the resident intra-islet APCs. The abun-
dant concentration of insulin in  cells combined with the 
existence of preformed insulin peptides and the constant local 
sampling and presentation by resident intra-islet APCs out-
weigh the poor biochemical properties of this register and 
allows for efficient presentation (Mohan et al., 2010, 2011). 
An important new finding concerns the requirement for rec-
ognition of immunogenic insulin in islets for localization of 
8F10 T cells as exemplified in their absence in B16A mice. The 
finding denotes immunological specificity for the localization 
of the diabetogenic T cells. In previous studies, we indicated 
that the localization of specific diabetogenic T cells did not 
require chemokine responses (Calderon et al., 2011a). Intra-
islet APCs are closely associated with the islet vasculature and 
extend dendrites through the fenestrated endothelium into the 
lumen of the islet capillaries (Calderon et al., 2011b). Although 
not conclusive, it is likely that these dendrites, protruding into 
the local bloodstream and highly charged with B:9-23 pep-
tide–MHC, can actively recruit insulin-reactive T cells directly 
from the adjacent bloodstream into the islets.
An important new finding is that 8F10 T cells migrated 
into the islets even though they had not been activated in the 
PLN and caused diabetes. These findings place a qualification 
on the role of the PLN. It raises important issues concerning 
the interaction between insulin-reactive T cells, believed to be 
among the earliest infiltrating immune cells, and other islet-
reactive CD4+ and CD8+ T cells in which the PLN is an inte-
gral site of activation. Our findings that very few T cells were 
found in the islets of the B16A mice is another argument for 
insulin T cells driving the initiation of diabetes. Moreover, 
does the recruitment of insulin-reactive T cells directly into the 
islets influence levels of islet antigen presentation in the PLN? 
It is conceivable that inflammation induced by early infiltrat-
ing, insulin-specific T cells leads to an increase in islet-specific 
antigen presentation in the PLN, providing both amplification 
and diversification of the antiislet response necessary for dia-
betes development. In strong support of this statement are the 
findings in which a robust CD8+ T cell response in the PLN 
to a class I MHC epitope derived from the islet-specific glucose-
6-phosphate catalytic subunit depended on the prior develop-
ment of the antiinsulin response (Krishnamurthy et al., 2006).
The emergence of antiinsulin antibodies and the localiza-
tion in islets was a surprise. A prior study showed that the TCR 
 chain from insulin-reactive T cells was sufficient to induce 
circulating insulin autoantibodies (Kobayashi et al., 2008). 
Our findings indicate that the 8F10 is acting as a helper T cell 
for B cells that react with native insulin. These findings are in-
triguing in the perspective of where B cells interact with in-
sulin, that is, whether with circulating insulin, or directly inside 
the islets. Although we do not have evidence that the IgG in 
islets or the intra-islet B cells are insulin-reactive, it is tempt-
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with 105 CD11c+ DC isolated from NOD mice treated with Flt-3L at indi-
cated doses of antigens. Flt-3L treatment was used to increase the yield of DC 
present in treated mice. Both CD4+ T cells and CD11c+ DC were isolated 
from spleens of donor mice using standard magnetic cell separation (Miltenyi 
Biotec). In other assays with 8F10 rag1/ mice, unfractionated splenocytes at 
a density of 5 × 105 cells per well were used. Proliferation was measured by 
[3H]thymidine incorporation over the last 24 h of a 72-h culture. ELISPOT 
assays were performed according to the manufacturer’s protocol: 8F10 rag1/ 
splenocytes were incubated overnight with antigen and analyzed for IL-2 
secretion. Insulin was purchased from Sigma-Aldrich. All peptides used in this 
study were synthesized in the laboratory using standard protocols and were 
previously described. In brief, nested register peptides, based off the native 
B:9-23 peptide SHLVEALYLVCGERG, were synthesized with identical 
artificial flanking residues using the following sequences: 12–20 core, TEG-
VEALYLVCG-GGS; 12–21 core, EGVEALYLVCGE-GGS; 13–21 core, 
TEG-EALYLVCGE-GGS; and 14–22 core; TEG-ALYLVCGER GGS.
In vivo T cell activation assays. Activation of T cells in vivo was per-
formed using a standard adoptive transfer system using CFSE-labeled sple-
nocytes. In brief, splenocytes were dissociated into a single-cell suspension. 
After RBC lysis, splenocytes were washed two times in PBS and incubated 
with 1.6-µM CFDA SE (Life Technologies) per 107 cells for 10 min at 37°C. 
Reaction was stopped by adding an equal volume of DMEM + 10% FCS. 
In other assays CD4+ CD25 splenic primary T cells were isolated by mag-
netic cell separation (Miltenyi Biotec) before labeling. After CFSE labeling, 
2–5 × 107 labeled splenocytes or 0.5–1 × 107 CD4+ CD25 purified T cells 
were transferred i.v. into NOD recipients. Inguinal, PLNs, and/or islets were 
harvested 72 or 120 h after transfer and dissociated into single-cell suspen-
sions. Adoptively transferred CFSE cells were gated either on CD3e+ or CD4+ 
for 8F10 and BDC 2.5, and by TCR V8.1/8.2+ CFSE+ and TCR V 4+ 
CFSE+, respectively.
Antiinsulin antibody detection and diabetes monitoring. 125I-labeled 
insulin was purchased from Perkin Elmer (Cat# NEX420010UC). 125I-insulin 
(150,000 cpm) was added to tubes containing sera with or without 10 µg/ml 
unlabeled insulin as competitor and incubated at 4°C for 72 h. After incuba-
tion, 25 µl of 25% Protein-A Sepharose was added and incubated on ice for 
1–2 h, shaking periodically. The entire sample was layered over 200 µl of an 
oil mixture [60% dibutylphthalate (Acros #16660-0010)/40% dioctylphthal-
ate (Acros #11709-0010)] in micro test tubes (Bio-Rad Laboratories). Tubes 
were spun for 4 min in a Beckman 152 microfuge. After spinning, tubes were 
cut above the pelleted Sepharose, and both the Sepharose pellet and superna-
tant were counted in a gamma counter.
LtR-Ig treatment. Pregnant female breeders used to generate 8F10 
and 8F10 rag1/ offspring were treated with soluble LtR-Ig using a 
previously established protocol (Rennert et al., 1996). Timed pregnant 
females were treated i.v. with 200 µg of soluble LtR-Ig fusion protein 
on days 14 and 17 of gestation. Progeny used in this study were visually 
inspected and determined to be devoid of ILNs, PLNs, popliteal LNs, and 
axillary LNs.
Statistical analysis. Mann–Whitney U test was used to determine the level 
of significant differences between samples and was plotted using GraphPad 
Prism 5 (GraphPad Software, Inc.).
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type B–reactive T cells on the other hand, pass through thy-
mic selection with relative ease and potentially represent the 
majority of true pathogenic insulin-reactive T cells.
In conclusion, it is becoming more evident that insulin-
reactive type B T cells represent not only a particularly rele-
vant autoreactive T cell population, but are also central players 
in the response against B:9-23 during diabetogenesis. Under-
standing of the pathogenic and/or suppressive capabilities of 
type A and B subsets independently during the disease process 
will not only benefit the basic understanding of autoimmunity 
in NOD mice, but may also aid in the future development of 
antigen-specific therapies aimed at preventing type 1 diabetes.
MATERIALS AND METHODS
Mice. NOD, NOD.Cg-Tg(TcraBDC2.5,TcrbBDC2.5)1Doi/DoiJ (BDC 
2.5), NOD.Cg-Tg(TcraTcrbNY8.3)1Pesa/DvsJ (8.3-NOD), NOD on 
the rag1/, and NOD.Cg-Tg(Ins2*Y16A)1Ell Ins1tm1Jja Ins2tm1Jja/GseJ 
(B16:A-dKO) were obtained from The Jackson Laboratory and maintained 
in specific pathogen–free conditions. All animal studies were approved by 
the animal study committee of Washington University.
Generation of 8F10 TCR transgenic mice. To generate the transgenic mice, 
the TCR  chain (V13.3, TRAV5D-4/TRAJ53) and  chain (V8.2, 
TRBV13-2/TRBD2/TRBJ2-7) sequences were isolated by PCR from cDNA 
sequences generated from the 8F10 T cell. The TCR  and  chains were 
cloned into CD2 and CD4 expression vectors, respectively (Zhumabekov et al., 
1995; Wang et al., 2001). Linearized TCR  and  expression constructs were 
co-injected into NOD embryos. Mice were genotyped by PCR with the fol-
lowing primer pairs; TCR  forward 5-GCAGTCTCCAAAGAATTCGC-
CACC-3 and TCR  reverse 5-CAGTTTGTAATTGCTGCCTCCACT-3; 
TCR  forward 5-ATGCACTGCTGCTATTGCTCAGGA-3 and TCR  
reverse 5-CCGCTGGCACAGAAGTACACTGAT-3.
Flow cytometry. Single-cell suspensions isolated from various organs were 
stained with the following antibodies against CD8, TCR V 8.1/8.2, TCR 
V 4, TCR V 2, and CD62L (BD); CD3e and Foxp3 (eBioscience); and 
CD4, CD69, and CD44 (BioLegend). Stainings were performed according 
to the manufacturer’s protocol. Flow cytometry samples were collected 
using a FACSCalibur and FACSCanto II flow cytometers (BD) and analyzed 
using Flow Jo software (Tree Star).
Islet isolation and handling for immunofluorescence. Islets were isolated 
with some modifications of the original protocol (Lacy and Kostianovsky, 
1967; Salvalaggio et al., 2002; Li et al., 2009). In brief, pancreata were iso-
lated and treated with collagenase, followed by several steps of centrifugation 
and washing, and finally, islets were picked by hand. Immunofluorescence 
analysis was performed as previously described (Calderon et al., 2008). Isolated 
islets maintained on ice were preincubated with 10% Fc block, followed by 
staining with specific labeled monoclonal antibodies for: anti-CD11c Alexa 
Fluor 488 (clone N418) and anti-CD4 PE (clone RM4-5; BioLegend); anti-
TCR V 8.1/8.2 PE (clone MR5-2; BD); anti-CD31 Alexa Fluor 647 
(clone 2B8; provided by S. Bogen, Boston University School of Medicine, 
Boston, MA); goat anti–mouse IgG (H+L) Alexa Fluor 488 (Life Technologies); 
and biotinylated anti–VCAM-1 (clone 429; eBioscience). Streptavidin Alexa 
Fluor 555 (Life Technologies) was used as the secondary reagent. Islets were 
fixed in 1% paraformaldehyde before epi-illumination microscopic analysis. 
Percentages of islets with infiltrating T cells, VCAM-1 expression, and IgG 
deposition were generated by scoring 100 individual purified islets from a 
pool of five mice per group.
In vitro T cell activation assays. Proliferation of primary 8F10 T cells was 
performed in triplicate in 96-well round bottom tissue culture plates. 105 
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